DZ Bank
EDIT icon

DZ Bank’s Editas Medicine EDIT Stock Holding History

DZ Bank’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,057,100
Closed -$29.4M – 1019
2021
Q4 		$29.4M Buy
1,057,100
+528,550
+100% +$18.2M 0.02% 309
2021
Q3 		$21.7M Hold
528,550
– – 0.03% 268
2021
Q2 		$29.9M Hold
528,550
– – 0.05% 222
2021
Q1 		$22.2M Buy
+528,550
New +$30.1M 0.04% 244

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

DZ Bank's EDIT Position: Q1 2022 in Review

DZ Bank sold out of Editas Medicine (EDIT) in Q1 2022, closing a stake of 1,057,100 shares — an estimated $29.4M sold.

DZ Bank first reported a position in EDIT in Q1 2021 and held it in 4 quarters. The position peaked at $29.9M in Q2 2021. 256 funds tracked by Wall St. Rank hold EDIT as of Q1 2022.

  • DZ Bank reported no remaining Editas Medicine position as of Q1 2022 after selling out during the quarter.
  • DZ Bank sold 1,057,100 Editas Medicine shares in Q1 2022, an estimated $29.4M.
  • DZ Bank first reported a position in Editas Medicine in Q1 2021 and held it in 4 quarters.
  • DZ Bank's Editas Medicine position peaked at $29.9M in Q2 2021.
  • 256 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2022.

Based on DZ Bank's 13F filing for Q1 2022, filed 16 May 2022.